We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ECBK:NASDAQECB Bancorp, Inc. Analysis

Data as of 2026-06-13 - not real-time

$19.32

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

ECB Bancorp (ECBK) is trading at $19.32, comfortably above its 20‑day ($18.39), 50‑day ($18.24) and 200‑day ($17.20) simple moving averages, and the RSI sits at 64, indicating solid upward momentum without being overbought. The MACD histogram is positive and the MACD signal is bullish, while volume has been increasing, all pointing to a short‑term bullish trend. The stock is near a technical resistance around $19.70 and has a support level near $17.52, leaving modest upside potential toward the DCF‑derived fair value of $20.85.
Fundamentally, the company posted a 44% year‑over‑year revenue surge to $34.8 M, with an operating margin of 45% and a profit margin of 27.6%, underscoring strong profitability. Valuation metrics are attractive: a PE of 16.7 is in line with the industry average of 16.8, the price‑to‑book ratio is below 1 (0.96), and the DCF suggests the stock is undervalued. Low beta (0.42) and a 30‑day volatility of ~23% indicate limited systematic risk, though regional‑bank regulatory exposure remains a consideration.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price trading just below technical resistance at $19.70
  • bullish MACD and RSI indicating upward momentum
  • increasing volume supporting short‑term demand

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 44% YoY revenue growth driving earnings expansion
  • high operating margin (45%) delivering strong profitability
  • DCF fair value of $20.85 suggests upside from current price

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • price‑to‑book below 1 provides a margin of safety
  • low beta (0.42) reduces exposure to market swings
  • potential recovery and consolidation in the regional‑bank sector

Key Metrics & Analysis

Financial Health

Revenue Growth44.40%
Profit Margin27.59%
P/E Ratio16.7
ROE5.57%
ROA0.62%
P/B Ratio1.0
Op. Cash Flow$12.7M
Industry P/E16.8

Technical Analysis

TrendBullish
RSI64.3
Support$17.52
Resistance$19.70
MA 20$18.39
MA 50$18.24
MA 200$17.20
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair Value$20.85
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.42
Volatility22.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.